Predict your next investment

Hexaell Biotech company logo
HEALTHCARE | Biotechnology
hexaell.com

See what CB Insights has to offer

Founded Year

2015

Stage

Series A | Alive

Total Raised

$7.25M

Last Raised

$7.25M | 3 yrs ago

About Hexaell Biotech

Hexaell Biotech is a biopharmaceutical company focused on severe liver disease and cell therapy using cell differentiation and production technology.

Hexaell Biotech Headquarter Location

Building D No. 55 Huiyuan Road

Shanghai, Shanghai,

China

+86 021-59967620

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Hexaell Biotech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Hexaell Biotech is included in 2 Expert Collections, including Biopharmaceuticals.

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

R

Regenerative Medicine

1,767 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.